Synchronous disease does not predict long-term outcomes in patients with resected colorectal cancer liver metastases

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter M. Marques
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors M. Marques1, H.S. de Castro Ribeiro2, W..L. Costa2, A.L. Diniz2, A. Godoy1, I. Farias1, F. Antonio Cury1, F.J. Fernandez Coimbra2
  • 1A.C. Camargo Cancer Center, São Paulo, Brazil, /
  • 2Hospital A.C. Camargo, Sao Paulo, Brazil, /


For long-time, synchronous colorectal liver metastases (SCLM) has been recognized as an adverse prognostic factor for patients with colorectal cancer. However more recent data has questioned its impact in long-term survival. This cohort analyzes the impact of SCLM in long-term survival of patients treated in a referral Brazilian oncologic center.